• Mubritinib (TAK 165): A Causal OXPHOS Assay Framework

  2026-08-25

  Mubritinib (TAK 165) can be used as a mechanistic probe of complex I dependence rather than as a generic cytotoxic agent. This article combines cancer metabolism, apoptosis readouts, and causal assay design inspired by comparative mitochondrial research.

• 740 Y-P: PI 3-Kinase Activator Guide

  2026-08-25

  740 Y-P is a cell-permeable PI 3-kinase activator for controlled PI3K/AKT pathway modulation. Product-dossier benchmarks support its use in vesicular trafficking research, neuronal cell survival studies, and cancer-related cellular assays, while a 2026 chondrocyte study used it as a PI3K agonist for pathway validation.

• Cucurbitacin I (JSI-124) STAT3 Workflow Guide

  2026-08-24

  Build a decision-ready STAT3 workflow with Cucurbitacin I (JSI-124), linking phospho-STAT3 suppression to apoptosis, proliferation, invasion, and drug-sensitization outcomes. The guide also shows how an assembloid study can inspire layered assay design without overstating cross-domain evidence.

• SMYD2 Inhibition in Cisplatin-Induced Renal Fibrosis

  2026-08-23

  The reference study identifies SMYD2 as a pharmacologically actionable regulator of cisplatin-induced chronic kidney disease, linking its increased expression to renal fibrosis, inflammation, and epithelial-to-fibrogenic transition. Using AZ505 and LLY507 in animal and tubular epithelial-cell models, the authors show that SMYD2 inhibition improves renal injury-associated outcomes and modulates Smad3, STAT3, and Smad7 signaling.

• BRD4 Inhibition Enhances Erastin-Induced Ferroptosis

  2026-08-22

  This 2024 Discover Oncology study shows that pharmacological or genetic BRD4 inhibition sensitizes several cell lines to erastin-induced ferroptosis. The work connects this effect to reactive oxygen species accumulation and reduced FSP1 expression, supporting mechanistically informed combinations of BET inhibitors with ferroptosis inducers in cancer biology research.

• Ribociclib, pH Shifts, and Acid-Reducing Agents

  2026-08-21

  The reference study combines Analytical Quality by Design with a biorelevant micro-dissolution model to examine whether gastric and intestinal pH shifts alter ribociclib succinate behavior. Although measurable solubility decreases occurred after each pH transition, the authors concluded that acid-reducing-agent-associated pH changes were unlikely to produce a major effect on ribociclib absorption under the tested conditions.

• How Impending Cell Death Seeds Metastasis

  2026-08-21

  Conod, Silvano, and Ruiz i Altaba identify a mechanism in which tumor cells surviving impending death acquire stable prometastatic states called PAMEs. Their work links ER stress, PERK–CHOP signaling, GLI/NANOG-mediated reprogramming, and cytokine-driven recruitment of neighboring PIM cells, offering a mechanistic framework for how metastatic ecosystems may arise within primary tumors.

• Bestatin (Ubenimex) Workflows for Aminopeptidase Research

  2026-08-20

  Build cleaner aminopeptidase activity measurement, apoptosis assay, and multidrug resistance workflows with Bestatin (Ubenimex). This guide combines enzyme-level controls, cell-based optimization, and a careful translation of necroptosis findings from a viral immunology study without overstating what the compound proves.

• YM-155 Hydrochloride: Survivin Inhibitor Guide

  2026-08-20

  YM-155 hydrochloride is a selective small-molecule survivin inhibitor with a reported survivin-suppressive IC50 of 0.54 nM. Product evidence supports its use in apoptosis inhibitor research, cancer-cell proliferation assays, and tumor regression in xenograft models, while experimental interpretation should distinguish growth inhibition from cell death.

• PPT and ERα: A Better LUAD Assay Logic

  2026-08-19

  PPT (Propyl Pyrazole Triol) enables precise ERα perturbation in estrogen receptor signaling studies. This article translates female lung adenocarcinoma biomarker findings into a rigorous assay strategy that separates association, receptor activity, and functional consequence.

• Targeted CRISPRi Against Fabp4 in Obesity

  2026-08-18

  Chung and colleagues developed a nonviral, adipose-targeted CRISPR interference system that represses Fabp4 in mature white adipocytes. In obese mice, this strategy was associated with lower body weight and inflammation, improved hepatic steatosis, and restoration of insulin sensitivity, illustrating how cell-selective gene regulation can address interconnected metabolic phenotypes.

• Gastric Cancer Assembloids: Modeling Tumor–Stroma Biology

  2026-08-18

  The reference study develops patient-derived gastric cancer assembloids by combining matched tumor organoids with tumor-derived stromal subpopulations. Its findings show that stromal composition alters gene expression and drug sensitivity, supporting more physiologically relevant studies of tumor heterogeneity, resistance, and personalized treatment.

• Lyotropic Phase Behavior in Coil-Bottlebrush Diblocks

  2026-08-17

  Rodriguez, Mahanthappa, and Lodge show that coil–bottlebrush diblock copolymers form diverse lyotropic morphologies in alkylimidazolium ionic liquids, even when solvent selectivity changes substantially with alkyl-chain length. The weak dependence on ionic-liquid identity provides a useful design principle for mapping nanostructure formation without treating each solvent as an entirely separate materials platform.

• Western Secondary Antibody Dilution Buffer for NHE1 Blots

  2026-08-17

  Learn how Western Secondary Antibody Dilution Buffer can improve reproducibility in mechanistic NHE1 and Olfr2 Western blot studies. This guide connects reagent stability and background control with pathway-specific assay design.

• Cell Senescence β-Galactosidase Staining Kit Workflow

  2026-08-16

  Use the Cell Senescence β-Galactosidase Staining Kit to convert SA-β-Gal activity into a visible blue endpoint for routine cellular senescence assay workflows. Its polystyrene compatibility, light-protected X-gal formulation, and suitability for cells or frozen sections make it useful for drug-response studies, mechanism validation, and senescent cell detection.

454 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page